OncLive

Bringing the Oncology Community Together

iTunes

YouTube

Login | Register

Related Articles

Photos From the 2011 ASH Annual Meeting and Exposition

Key Presentations and Meeting Takeaway Points

Chemotherapy Alone Increases Overall Survival for Early-stage Hodgkin Lymphoma

Key Presentations and Meeting Takeaway Points From SABCS

Dr. Kochenderfer Discusses the B-cell Antigen CD19

Key Presentations and Meeting Takeaway Points From ASH

Published Online: Tuesday, December 13th, 2011

Share:

Text Size:

A collection of video interviews from the American Society of Hematology (ASH) 53rd annual meeting at the San Diego Convention Center in San Diego, CA, from December 10-13, 2011.

Dr. Hugh-Jones Discusses the JAK2 Inhibitor SAR302503

Dr. Hugh-Jones Discusses the JAK2 Inhibitor SAR302503

Dr. Mato on the Benefits of the JTCC Retrospective Trial

Dr. Mato on the Benefits of the JTCC Retrospective Trial

Dr. Anasetti Discusses the Trade-offs of BMT and PBSC

Dr. Anasetti Discusses the Trade-offs of BMT and PBSC

Dr. Sehn on the Efficacy of the CD20 Agent GA101

Dr. Sehn Discusses the Efficacy of the CD20 Agent GA101

Dr. Kochenderfer Discusses the B-cell Antigen CD19

Dr. Kochenderfer Discusses the B-cell Antigen CD19

Dr. Feldman Discusses the Difficulties of Rare Lymphomas

Dr. Feldman Discusses the Difficulties of Rare Lymphomas

>>>Return to the main conference coverage page.

About Us | Advertise | Advisory Board | Archives | Contact Us | Forgot Password

External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest

OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2012
Intellisphere, LLC. All Rights Reserved.